CHRYSSA MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CHRYSSA MED
Largest movements
- Cash -€27,730
down €27,730 (-86.7%), from €31,986 to €4,256
mainly Receivables within one year (-€14,948) and Deferred charges and accrued income (-€10,496)
- Receivables within one year +€14,948
up €14,948 (+326%), from €4,581 to €19,529
- Deferred charges and accrued income +€10,496
new in 2025: €10,496
- Other debts -€6,948
no longer reported in 2025 (was €6,948)
- Reserves +€5,898
up €5,898 (+30.7%), from €19,211 to €25,109
- Current portion of long-term debt -€1,850
down €1,850 (-54.5%), from €3,393 to €1,543
- Trade debts +€614
up €614 (+30.5%), from €2,015 to €2,629
- Gross operating margin -€17,441
down €17,441 (-66.4%), from €26,266 to €8,826
- Taxes -€3,012
down €3,012 (-55.6%), from €5,419 to €2,407
- Other operating charges -€480
down €480 (-41.9%), from €1,147 to €667
- Financial income +€335
new in 2025: €335
- Financial charges -€302
down €302 (-61.6%), from €489 to €188
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €36,567 | €34,281 | -€2,285 | -6.3% |
| Current assets | 29/58 | €36,567 | €34,281 | -€2,285 | -6.3% |
| Amounts receivable within one year | 40/41 | €4,581 | €19,529 | +€14,948 | +326% |
| Other amounts receivable | 41 | €4,581 | €19,529 | +€14,948 | +326% |
| Cash at bank and in hand | 54/58 | €31,986 | €4,256 | -€27,730 | -86.7% |
| Deferred charges and accrued income | 490/1 | - | €10,496 | +€10,496 | |
| Total equity and liabilities | 10/49 | €36,567 | €34,281 | -€2,285 | -6.3% |
| Equity | 10/15 | €24,211 | €30,109 | +€5,898 | +24.4% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €19,211 | €25,109 | +€5,898 | +30.7% |
| Distributable reserves | 133 | €19,211 | €25,109 | +€5,898 | +30.7% |
| Amounts payable | 17/49 | €12,356 | €4,172 | -€8,184 | -66.2% |
| Amounts payable within one year | 42/48 | €12,356 | €4,172 | -€8,184 | -66.2% |
| Current portion of amounts payable after more than one year | 42 | €3,393 | €1,543 | -€1,850 | -54.5% |
| Trade debts | 44 | €2,015 | €2,629 | +€614 | +30.5% |
| Suppliers | 440/4 | €2,015 | €2,629 | +€614 | +30.5% |
| Other amounts payable | 47/48 | €6,948 | - | -€6,948 | |
| Other operating charges | 640/8 | €1,147 | €667 | -€480 | -41.9% |
| Gross operating margin | 9900 | €26,266 | €8,826 | -€17,441 | -66.4% |
| Operating profit (loss) | 9901 | €25,120 | €8,159 | -€16,961 | -67.5% |
| Financial income | 75/76B | - | €335 | +€335 | |
| Recurring financial income | 75 | - | €335 | +€335 | |
| Financial charges | 65/66B | €489 | €188 | -€302 | -61.6% |
| Recurring financial charges | 65 | €489 | €188 | -€302 | -61.6% |
| Profit (loss) for the period before taxes | 9903 | €24,630 | €8,306 | -€16,325 | -66.3% |
| Income taxes | 67/77 | €5,419 | €2,407 | -€3,012 | -55.6% |
| Profit (loss) for the period | 9904 | €19,211 | €5,898 | -€13,313 | -69.3% |
| Profit (loss) for the period to be appropriated | 9905 | €19,211 | €5,898 | -€13,313 | -69.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.